Literature DB >> 552461

Retinal vasculitis: a review.

M D Sanders.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 552461      PMCID： PMC1437225          DOI： 10.1177/014107687907201209

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  10 in total

Review 1.  Behçet's disease. Report of 41 cases and a review of the literature.

Authors:  T Chajek; M Fainaru
Journal:  Medicine (Baltimore)       Date:  1975-05       Impact factor: 1.889

2.  Retinal, choroidal, and optic disc involvement in sarcoidosis.

Authors:  M D Sanders; J S Shilling
Journal:  Trans Ophthalmol Soc U K       Date:  1976-04

3.  Circulating immune complexes in retinal vasculitis.

Authors:  B S Andrews; J McIntosh; V Petts; R Penny
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

4.  RETINAL VASCULITIS.

Authors:  T K Lyle; K Wybar
Journal:  Br J Ophthalmol       Date:  1961-12       Impact factor: 4.638

5.  Amelioration of endothelial abnormalities by prednisone in experimental thrombocytopenia in the rabbit.

Authors:  C S Kitchens
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

6.  Vasculitis with hepatitis B antigenemia: long-term observation in nine patients.

Authors:  J S Sergent; M D Lockshin; C L Christian; D J Gocke
Journal:  Medicine (Baltimore)       Date:  1976-01       Impact factor: 1.889

7.  Benign retinal vasculitis. Clinical and fluorescein angiographic study.

Authors:  C D Hart; M D Sanders; S J Miller
Journal:  Br J Ophthalmol       Date:  1971-11       Impact factor: 4.638

8.  Granulomatous angiitis of the central nervous system.

Authors:  E H Kolodny; J J Rebeiz; V S Caviness; E P Richardson
Journal:  Arch Neurol       Date:  1968-11

9.  Ocular clinical findings and basement membrane changes in Goodpasture's syndrome.

Authors:  L M Jampol; M Lahov; D M Albert; J Craft
Journal:  Am J Ophthalmol       Date:  1975-03       Impact factor: 5.258

10.  Immune complexes in Behçet's syndrome and recurrent oral ulceration.

Authors:  B D Williams; T Lehner
Journal:  Br Med J       Date:  1977-05-28
  10 in total
  9 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 2.  Retinal vasculitis.

Authors:  M D Sanders; E M Graham
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

3.  Circulating antigen-antibody complexes in onchocerciasis.

Authors:  M W Steward; B Sisley; C D Mackenzie; H El Sheikh
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

4.  Hydralazine induced lupus syndrome with eye disease.

Authors:  M Doherty; P J Maddison; R H Grey
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

5.  To Study the Role of Serum Homocysteine Levels and Ocular Involvement in Retinal Vasculitis.

Authors:  Angad Miskin; Raji Kurumkattil; Anurodh Gupta; Hemant Singh Trehan; Puja Dudeja; Sanjay Kumar Dhar; Vijay Kumar Sharma
Journal:  Indian J Clin Biochem       Date:  2021-04-20

6.  Experimental posterior uveitis. I: A clinical, angiographic, and pathological study.

Authors:  M R Stanford; E C Brown; E Kasp; E M Graham; M D Sanders; D C Dumonde
Journal:  Br J Ophthalmol       Date:  1987-08       Impact factor: 4.638

7.  Retinal vasculitis in rheumatoid arthritis.

Authors:  M F Martin; D G Scott; C Gilbert; P A Dieppe; D L Easty
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

8.  Profile of retinal vasculitis in a tertiary eye care center in Eastern India.

Authors:  Kumar Saurabh; Radha R Das; Jyotirmay Biswas; Amitabh Kumar
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

9.  Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report.

Authors:  Katherine J Donnithorne; Russell W Read; Robert Lowe; Peter Weiser; Randy Q Cron; Timothy Beukelman
Journal:  Pediatr Rheumatol Online J       Date:  2013-06-04       Impact factor: 3.054
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.